Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae

被引：9
|
作者：
Morrissey, I. [1 ]
Maher, K. [1 ]
Hawser, S. [2 ]
机构：
[1] Quotient Biores Ltd, Microbiol, Fordham CB7 5WW, England
[2] Arpida AG, CH-4153 Reinach, Switzerland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2009年 / 63卷 / 02期
关键词：
INFECTIONS; RESISTANCE; EUROPE;
D O I：
10.1093/jac/dkn505
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [21] Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections
    Takahashi, T.
    Sunaoshi, K.
    Sunakawa, K.
    Fujishima, S.
    Watanabe, H.
    Ubukata, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (08) : 1097 - 1103
  • [22] Antibacterial Activity of Rhodomyrtus tomentosa (Aiton) Hassk. Leaf Extract against Clinical Isolates of Streptococcus pyogenes
    Limsuwan, Surasak
    Kayser, Oliver
    Voravuthikunchai, Supayang Piyawan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [23] Antibacterial activity and mechanism of berberine against Streptococcus agalactiae
    Peng, Lianci
    Kang, Shuai
    Yin, Zhongqiong
    Jia, Renyong
    Song, Xu
    Li, Li
    Li, Zhengwen
    Zou, Yuanfeng
    Liang, Xiaoxia
    Li, Lixia
    He, Changliang
    Ye, Gang
    Yin, Lizi
    Shi, Fei
    Lv, Cheng
    Jing, Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5217 - 5223
  • [24] Antibacterial activity and mechanism of chelerythrine against Streptococcus agalactiae
    Xin, Jige
    Pu, Qiqi
    Wang, Ruiying
    Gu, Yeqing
    He, Lin
    Du, Xuan
    Tang, Guowen
    Han, Diangang
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [25] In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
    Banche, G.
    Roana, J.
    Allizond, V.
    Andreotti, S.
    Malabaila, A.
    Vigni, N. Li
    Mandras, N.
    Scalas, D.
    Tullio, V.
    Carlone, N. A.
    Savoia, D.
    Gaido, E.
    Barbui, A.
    Cuffini, A. M.
    LETTERS IN APPLIED MICROBIOLOGY, 2008, 47 (04) : 309 - 314
  • [26] Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes
    Cascone, C
    Santagati, M
    Noviello, S
    Iannelli, F
    Esposito, S
    Pozzi, G
    Stefani, S
    MICROBIAL DRUG RESISTANCE, 2002, 8 (02) : 129 - 132
  • [27] In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
    Giovanetti, E
    Montanari, MP
    Marchetti, F
    Varaldo, PE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 905 - 908
  • [28] In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae:: Mechanisms of macrolide and tetracycline resistance
    Betriu, C
    Culebras, E
    Rodríguez-Avial, I
    Gómez, M
    Sánchez, BA
    Picazo, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 323 - 325
  • [29] COAGGREGATION BETWEEN ACTINOMYCES-VISCOSUS WITH STREPTOCOCCUS-PYOGENES AND STREPTOCOCCUS-AGALACTIAE
    CHISARI, G
    GISMONDO, MR
    MICROBIOLOGICA, 1986, 9 (03): : 393 - 398
  • [30] Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against streptococcus pyogenes clinical isolates with different genotypes and phenotypes
    Drago, L
    Ripa, S
    Zampaloni, C
    De Vecchi, E
    Vitali, LA
    Petrelli, D
    Prenna, M
    CHEMOTHERAPY, 2005, 51 (05) : 268 - 271
12345